Skip to content

The effect of locally applied platelet-rich fibrin on donor sites and recipient sites after split-thickness skin transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN01737461
Enrollment
20
Registered
2006-02-17
Start date
2006-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic leg ulcer Circulatory System Chronic leg ulcer

Interventions

Split-thickness skin transplantation

Sponsors

Vivolution A/S (Denmark)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing surgery for chronic leg ulcer 2. Aged over 18 years 3. Written informed consent, the patient is expected to be able to complete the study 4. Donor site area from 2 x (3 cm x 5 cm) to 2 x (7.6 cm x 15 cm)

Exclusion criteria

Exclusion criteria: 1. Non-Danish speaking 2. Dementia 3. Pregnant or breastfeeding women 4. Patients treated with 10 mg of steroid or more daily 5. Patients that have received thrombocyte-inhibiting medicine less than four days before surgery 6. Patients not suited for general or spinal anaesthesia 7. Patients whose donor site has been used as a donor site before 8. Patients with skin diseases or pathological changes in the skin, including infection

Design outcomes

Primary

MeasureTime frame
Epithelialization on day five and nine post-operatively

Secondary

MeasureTime frame
1. Clinical appearance 2. Histological evaluation 3. Transepidermal Water Loss (TEWL) 4. Erythema 5. Microbiology 6. Incidence of infection 7. Unwanted side effects 8. Temperature difference between treated patients and control group patients

Countries

Denmark

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026